The investment bank Arjil – Groupe Altium has advised JRI’s shareholders for the sale of the company to Turenne Santé, Bpifrance and InnovaFonds as part of an LMBI.
JRI is the French leading specialist in the design and distribution of wireless monitoring solutions and chart recorders for controlling and monitoring physical quantities such as temperature, relative humidity, pressure, water consumption and electricity consumption. JRI’s products and solutions are targeted to professional clients, mainly in the life sciences, food and beverage and industrial sectors.
JRI generated approximately 12 million euros in turnover during the year 2014.
JRI was owned since 2001 by its management (Thierry Vayssette and Anne Beaufils) and private investors.
In this transaction Arjil capitalised on both its strong experience of the industry and services sectors and its recognized expertise in managing high value-added transactions. Arjil acted as the sole financial adviser to JRI’s shareholders.
Several European, north-American and Asian industry players as well as financial investors were targeted as potential acquirers. Pascal Vermeersch, former manager of and investor in service SMEs, together with Turenne Santé, Bpifrance and InnovaFonds, were ultimately selected.
Wladimir Mollof, Arjil & Partners’ chairman, says: “The expertise of JRI, whether in security or connected objects, aroused much interest both in France and abroad. Shareholders sought to sell their shares to a buyer capable of developing the group in fast growing markets, boosting its innovation capacity and ensuring its sustainability while respecting its identity. Arjil, which advises international groups as well as SMEs, has been able to identify the right players and build financial engineering supporting the projects and ambitions of each party”.
